Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial

{ 'indexed': {'date-parts': [[2022, 9, 23]], 'date-time': '2022-09-23T22:07:57Z', 'timestamp': 1663970877829}, 'reference-count': 32, 'publisher': 'Elsevier BV', 'issue': '6', 'license': [ { 'start': { 'date-parts': [[2021, 6, 1]], 'date-time': '2021-06-01T00:00:00Z', 'timestamp': 1622505600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.fr', 'clinicaltherapeutics.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 6]]}, 'DOI': '10.1016/j.clinthera.2021.04.007', 'type': 'journal-article', 'created': {'date-parts': [[2021, 5, 6]], 'date-time': '2021-05-06T22:12:22Z', 'timestamp': 1620339142000}, 'page': '1007-1019', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 29, 'title': 'Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, ' 'Controlled Clinical Trial', 'prefix': '10.1016', 'volume': '43', 'author': [ {'given': 'Leila', 'family': 'Shahbaznejad', 'sequence': 'first', 'affiliation': []}, {'given': 'Alireza', 'family': 'Davoudi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gohar', 'family': 'Eslami', 'sequence': 'additional', 'affiliation': []}, {'given': 'John S.', 'family': 'Markowitz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad Reza', 'family': 'Navaeifar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fatemeh', 'family': 'Hosseinzadeh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Faeze Sadat', 'family': 'Movahedi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammad Sadegh', 'family': 'Rezai', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.clinthera.2021.04.007_bib0001', 'doi-asserted-by': 'crossref', 'first-page': '139', 'DOI': '10.32598/jpr.8.2.139', 'article-title': 'COVID-19 infection in Iranian children: a case series of 9 patients', 'volume': '8', 'author': 'Rahimzadeh', 'year': '2020', 'journal-title': 'Journal of Pediatrics Review'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s12887-020-02415-z', 'article-title': 'Clinical characteristics of 10 children with a pediatric inflammatory ' 'multisystem syndrome associated with COVID-19 in Iran', 'volume': '20', 'author': 'Shahbaznejad', 'year': '2020', 'journal-title': 'BMC Pediatrics'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0003', 'unstructured': 'COVID-19 Coronavirus Pandemic [worldometer website]. 2020. Available at: ' 'https://www.worldometers.info/coronavirus. Accessed at 18 April 2021.'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0004', 'article-title': 'Current targeted therapeutics against COVID-19: based on first-line ' 'experience in china', 'author': 'Zhang', 'year': '2020', 'journal-title': 'Pharmacological Research'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'article-title': 'Dexamethasone in hospitalized patients with Covid-19—preliminary report', 'volume': '384', 'author': 'Horby', 'year': '2021', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0006', 'doi-asserted-by': 'crossref', 'article-title': 'Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 ' 'drug treatment', 'author': 'Essid', 'year': '2020', 'journal-title': 'Marine Pollution Bulletin', 'DOI': '10.1016/j.marpolbul.2020.111375'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '1156', 'DOI': '10.4269/ajtmh.20-0271', 'article-title': 'Ivermectin and COVID-19: keeping rigor in times of urgency', 'volume': '102', 'author': 'Chaccour', 'year': '2020', 'journal-title': 'The American Journal of Tropical Medicine and Hygiene'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0008', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antiviral Research'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0009', 'first-page': '1', 'article-title': 'Ivermectin: a systematic review from antiviral effects to COVID-19 ' 'complementary regimen', 'author': 'Heidary', 'year': '2020', 'journal-title': 'The Journal of Antibiotics'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '1153', 'DOI': '10.1007/s00210-020-01902-5', 'article-title': 'Ivermectin, antiviral properties and COVID-19: a possible new mechanism ' 'of action', 'volume': '393', 'author': 'Rizzo', 'year': '2020', 'journal-title': 'Naunyn Schmiedebergs Arch Pharmacol'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '369', 'DOI': '10.1016/j.bjid.2020.06.002', 'article-title': 'Ivermectin: potential candidate for the treatment of Covid 19', 'volume': '24', 'author': 'Gupta', 'year': '2020', 'journal-title': 'The Brazilian Journal of Infectious Diseases'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0012', 'unstructured': 'Critical Care COVID-19 Management Protocol [Eastern Virginia Medical ' 'School website]. Available at: ' 'https://www.evms.edu/media/evms_public/departments/internal_medicine/Marik-Covid-Protocol-Summary.pdf. ' 'Accessed at 18 April 2021.'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '58', 'DOI': '10.5582/ddt.2020.01012', 'article-title': 'Discovering drugs to treat coronavirus disease 2019 (COVID-19)', 'volume': '14', 'author': 'Dong', 'year': '2020', 'journal-title': 'Drug Discoveries & Therapeutics'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '214', 'DOI': '10.1016/j.ijid.2020.11.191', 'article-title': 'A five day course of ivermectin for the treatment of COVID-19 may ' 'reduce the duration of illness', 'volume': '103', 'author': 'Ahmed', 'year': '2021', 'journal-title': 'International Journal of Infectious Diseases'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '10', 'DOI': '10.3329/jbcps.v38i0.47512', 'article-title': 'A case series of 100 COVID-19 positive patients treated with ' 'combination of ivermectin and doxycycline', 'author': 'Alam', 'year': '2020', 'journal-title': 'Journal of Bangladesh College of Physicians and Surgeons'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0016', 'doi-asserted-by': 'crossref', 'article-title': 'Chest CT findings in coronavirus disease-19 (COVID-19): relationship to ' 'duration of infection', 'author': 'Bernheim', 'year': '2020', 'journal-title': 'Radiology', 'DOI': '10.1148/radiol.2020200463'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s13063-020-04813-1', 'article-title': 'Ivermectin to prevent hospitalizations in patients with COVID-19 ' '(IVERCOR-COVID19): a structured summary of a study protocol for a ' 'randomized controlled trial', 'volume': '21', 'author': 'Vallejos', 'year': '2020', 'journal-title': 'Trials'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0018', 'doi-asserted-by': 'crossref', 'first-page': '994', 'DOI': '10.1056/NEJMoa2007764', 'article-title': 'Remdesivir for the treatment of Covid-19—preliminary report', 'volume': '383', 'author': 'Beigel', 'year': '2020', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0019', 'first-page': 'E001', 'article-title': 'Interpretation of "Guidelines for the Diagnosis and Treatment of Novel ' 'Coronavirus (2019-NCOV) Infection by the National Health Commission ' '(Trial Version 5)"', 'volume': '100', 'author': 'Lin', 'year': '2020', 'journal-title': 'Zhonghua yi xue za zhi'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '1138', 'DOI': '10.1016/j.mayocp.2020.04.006', 'article-title': 'Association between hypoxemia and mortality in patients with COVID-19', 'volume': '95', 'author': 'Xie', 'year': '2020', 'journal-title': 'Mayo Clinic Proceedings'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '84', 'DOI': '10.1016/j.ijid.2020.06.038', 'article-title': 'Performance of pneumonia severity index and CURB-65 in predicting ' '30-day mortality in patients with COVID-19', 'volume': '98', 'author': 'Satici', 'year': '2020', 'journal-title': 'International Journal of Infectious Diseases'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0022', 'doi-asserted-by': 'crossref', 'first-page': 'e16', 'DOI': '10.1016/j.jinf.2020.04.021', 'article-title': 'Risk factors of critical & mortal COVID-19 cases: a systematic ' 'literature review and meta-analysis', 'volume': '81', 'author': 'Zheng', 'year': '2020', 'journal-title': 'Journal of Infection'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '1946', 'DOI': '10.1016/j.mayocp.2020.06.016', 'article-title': 'Developing an Ethics Framework for Allocating Remdesivir in the ' 'COVID-19 Pandemic', 'volume': '95', 'author': 'Lim', 'year': '2020', 'journal-title': 'Mayo Clinic Proceedings'}, { 'issue': '10236', 'key': '10.1016/j.clinthera.2021.04.007_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '1569', 'DOI': '10.1016/S0140-6736(20)31022-9', 'article-title': 'Remdesivir in adults with severe COVID-19: a randomised, double-blind, ' 'placebo-controlled, multicentre trial', 'volume': '395', 'author': 'Wang', 'year': '2020', 'journal-title': 'The Lancet'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '1787', 'DOI': '10.1056/NEJMoa2001282', 'article-title': 'A trial of lopinavir–ritonavir in adults hospitalized with severe ' 'Covid-19', 'volume': '382', 'author': 'Cao', 'year': '2020', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0026', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s40560-020-00453-4', 'article-title': 'Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic ' 'review and meta-analysis', 'volume': '8', 'author': 'Huang', 'year': '2020', 'journal-title': 'Journal of Intensive Care'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1038/s41368-020-0074-x', 'article-title': 'High expression of ACE2 receptor of 2019-nCoV on the epithelial cells ' 'of oral mucosa', 'volume': '12', 'author': 'Xu', 'year': '2020', 'journal-title': 'International Journal of Oral Science'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0028', 'doi-asserted-by': 'crossref', 'first-page': '823', 'DOI': '10.1055/s-0040-1710006', 'article-title': 'Platelets in coronavirus disease 2019', 'volume': '46', 'author': 'Larsen', 'year': '2020', 'journal-title': 'Seminars in thrombosis and hemostasis'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '1792', 'DOI': '10.1002/cbin.11403', 'article-title': 'Lymphopenia in COVID-19: Therapeutic opportunities', 'volume': '44', 'author': 'Fathi', 'year': '2020', 'journal-title': 'Cell Biology International'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0030', 'doi-asserted-by': 'crossref', 'first-page': '382', 'DOI': '10.4269/ajtmh.17-0042', 'article-title': 'Serious neurological adverse events after ivermectin—do they occur ' 'beyond the indication of onchocerciasis?', 'volume': '98', 'author': 'Chandler', 'year': '2018', 'journal-title': 'The American Journal of Tropical Medicine and Hygiene'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0031', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105933', 'article-title': 'Arguments in favour of remdesivir for treating SARS-CoV-2 infections', 'volume': '55', 'author': 'Ko', 'year': '2020', 'journal-title': 'International Journal of Antimicrobial Agents'}, { 'key': '10.1016/j.clinthera.2021.04.007_bib0032', 'first-page': '317', 'article-title': 'The multitargeted drug ivermectin: from an antiparasitic agent to a ' 'repositioned cancer drug', 'volume': '8', 'author': 'Juarez', 'year': '2018', 'journal-title': 'American Journal of Cancer Research'}], 'container-title': 'Clinical Therapeutics', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0149291821002010?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0149291821002010?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 11, 8]], 'date-time': '2021-11-08T00:51:56Z', 'timestamp': 1636332716000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0149291821002010'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 6]]}, 'references-count': 32, 'journal-issue': {'issue': '6', 'published-print': {'date-parts': [[2021, 6]]}}, 'alternative-id': ['S0149291821002010'], 'URL': 'http://dx.doi.org/10.1016/j.clinthera.2021.04.007', 'relation': {}, 'ISSN': ['0149-2918'], 'subject': ['Pharmacology (medical)', 'Pharmacology'], 'container-title-short': 'Clinical Therapeutics', 'published': {'date-parts': [[2021, 6]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, ' 'Randomized, Controlled Clinical Trial', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Clinical Therapeutics', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.clinthera.2021.04.007', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2021 Published by Elsevier Inc.', 'name': 'copyright', 'label': 'Copyright'}]}